Search results
Results from the WOW.Com Content Network
Discover the latest breaking news in the U.S. and around the world — politics, weather, entertainment, lifestyle, finance, sports and much more.
Docusate is the common chemical and pharmaceutical name of the anion bis(2-ethylhexyl) sulfosuccinate, also commonly called dioctyl sulfosuccinate (DOSS). [2] [3] [4]Salts of this anion, especially docusate sodium, are widely used in medicine as an emollient laxative and as stool softeners, by mouth or rectally. [1]
Micolette Micro-enema® contains 45 mg sodium lauryl sulphoacetate, 450 mg per 5 ml sodium citrate BP, and 625 mg glycerol BP [48] and is a small volume stimulant enema suitable where large-volume enemas are contra-indicated. [28]
I oppose. We do not need seperate articles on each salt. Docusate is also the common name. Doc James (talk · contribs · email) 21:58, 12 November 2018 (UTC) @Doc James: While "docusate" is the material's WP:COMMONNAME it appears that "docusate sodium" is how the stool softener product is labeled. Do a Google image search for "docusate salt".
ATC code A06 Drugs for constipation is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
From a more specific name: This is a redirect from a title that is a more specific name to a less specific, more general one.. It may be a more specialized term, include extraneous identifiers, or simply be worded more narrowly.
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
In Australia, packets of 275 mg tablets of naproxen sodium are Schedule 2 pharmacy medicines, with a maximum daily dose of five tablets or 1375 mg. In the United Kingdom, 250 mg tablets of naproxen were approved for OTC sale under the brand name Feminax Ultra in 2008, for the treatment of primary dysmenorrhoea in women aged 15 to 50. [45]